New Zealand markets closed

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
12.00+0.50 (+4.35%)
At close: 04:00PM EDT
11.76 -0.24 (-2.00%)
After hours: 07:32PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts20202020
Avg. Estimate-1.66-1.59-6.56-5.14
Low estimate-1.82-1.84-7.3-7.53
High estimate-1.17-0.99-4.953.59
Year ago EPS-2.68-3.37-9.05-6.56
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts20202018
Avg. Estimate9.14M11.26M42.31M130.97M
Low estimate6.54M7.48M31.77M52.38M
High estimate11.7M15.9M56.79M584.56M
Year ago sales2.47M2.72M86.45M42.31M
Sales growth (year/est)270.00%314.60%-51.10%209.50%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-2.55-2.73-1.28-1.65
Actual EPS-2.68-3.37-0.55-1.8
Difference-0.13-0.640.73-0.15
Surprise %-5.10%-23.40%57.00%-9.10%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.66-1.59-6.56-5.14
7 days ago-1.66-1.59-6.57-5.13
30 days ago-1.68-1.6-6.59-5.14
60 days ago-1.6-1.58-6.2-4.72
90 days ago-1.58-1.57-6.22-4.76
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days111N/A
Up last 30 days111N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/AN/A1
Growth estimatesSAGEIndustrySector(s)S&P 500
Current qtr.38.10%N/AN/AN/A
Next qtr.52.80%N/AN/AN/A
Current year27.50%N/AN/AN/A
Next year21.60%N/AN/AN/A
Next 5 years (per annum)16.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A